Effects of insulin-like growth factors-IR and -IIR antisense gene transfection on the biological behaviors of SMMC-7721 human hepatoma cells

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 3, 2003, Pages 296-301

  Yang, Jian Min ^a   Chen, Wen Sheng ^a   Liu, Zhi Peng ^a   Luo, Yuan Hui ^a   Liu, Wei Wen ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antisense gene; Hepatocellular carcinoma; Insulin like growth factors IR and IIR

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INSULIN LIKE GROWTH FACTOR IIR; INSULIN LIKE GROWTH FACTOR IR; SOMATOMEDIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLONOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; GENE THERAPY; GENETIC TRANSFECTION; GROWTH CURVE; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR CELL LINE; VIRAL GENE DELIVERY SYSTEM;

EID: 0037366614     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.02961.x     Document Type: Article

References (13)

1. Ly A, Francois JC, Upegui-Gonzalez LC et al. Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis. Life Sci. 2000; 68: 307-19.
2. Roy RN, Gerulath AH, Cecutti A et al. Loss of IGF-II imprinting in endometrial tumors: overexpression in carcinosarcoma. Cancer Lett. 2000; 153: 67-73.
3. Misawa A, Hosoi H, Arimoto A et al. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells. Cancer Res. 2000; 60: 64-9.
4. Jiang Y, Rom WN, Yie TA et al. Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-I receptor. Oncogene 1999; 18: 6071-7.
5. Chernicky CL, Yi L, Tan H et al. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo. Cancer Gene Ther 2000; 7: 384-95.
6. Zhou P, Zhou ZC, Chen WS et al. The inhibitory effects of IGF-IR antisense gene on the growth of human hepatoma cell line. Acta Acadeiae Med. Militaris Tertiae 1999; 21: 624-6 (in Chinese).
7. Chen WS, Liu WW, Gu JR et al. Effect on growth of human hepatoma cells by antisense gene of type II insulin-like growth factor receptor transfection. Chin J. Dig. 2001; 21: 263-6 (in Chinese).
8. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
9. Quinn KA, Treston AM, Unsworth EJ et al. Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem 1996; 271: 11477-83.
10. Scharf JG, Dombrowski F, Ramadori G. The IGF axis and hepatocarcinogenesis. Mol Pathol 2001; 54: 138-44.
11. Aihara T, Noguchi S, Miyoshi Y et al. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver. Hepatology 1998; 28: 86-9.
12. Yan Z, Deng X, Friedman E. Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III. J. Biol. Chem 2001; 276: 1555-63.
13. Rubini M, Hongo A, D'Ambrosio C et al. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp Cell Res. 1997; 230: 284-92.